Deborah Brown
Directeur/Membre du Conseil chez ONCOLYTICS BIOTECH INC.
Fortune : 185 348 $ au 30/04/2024
Profil
Deborah M.
Brown is an Independent Director at Oncolytics Biotech, Inc., Director at Life Sciences Ontario, Director & Managing Partner at Accelera Canada Ltd., and Director at Hamilton Burlington Spca.
She was formerly the Chairman at Innovative Medicines Canada, Independent Director at Sernova Corp., Independent Director at Cardiol Therapeutics, Inc., Director at BIOTECanada, Executive Vice President-US Neuroimmunology at EMD Serono, Inc., and Manager-International Regulatory at Pasteur Mérieux Connaught.
Brown holds an undergraduate degree from the University of Guelph and an MBA from the Richard Ivey School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0,15% | 07/03/2024 | 114 211 ( 0,15% ) | 123 348 $ | 30/04/2024 |
SERNOVA CORP.
0,07% | 25/04/2023 | 200 000 ( 0,07% ) | 62 000 $ | 30/04/2024 |
Postes actifs de Deborah Brown
| Sociétés | Poste | Début |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Directeur/Membre du Conseil | 02/11/2017 |
Accelera Canada Ltd.
 Accelera Canada Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The private company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market. | Directeur/Membre du Conseil | - |
| Life Sciences Ontario | Directeur/Membre du Conseil | - |
| Hamilton Burlington Spca | Directeur/Membre du Conseil | - |
Anciens postes connus de Deborah Brown
| Sociétés | Poste | Fin |
|---|---|---|
| SERNOVA CORP. | Directeur/Membre du Conseil | 30/05/2023 |
| CARDIOL THERAPEUTICS INC. | Directeur/Membre du Conseil | 07/09/2021 |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Président | 01/01/2014 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2014 |
| EMD Serono Canada, Inc. | Sales & Marketing | - |
Formation de Deborah Brown
| University of Guelph | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ONCOLYTICS BIOTECH INC. | Health Technology |
| SERNOVA CORP. | Health Technology |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Pasteur Mérieux Connaught | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
| Life Sciences Ontario | |
Accelera Canada Ltd.
Accelera Canada Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The private company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market. | Commercial Services |
| Hamilton Burlington Spca | |
| EMD Serono Canada, Inc. |
